[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001276748A1 - Highly absorbable solid preparation - Google Patents

Highly absorbable solid preparation

Info

Publication number
AU2001276748A1
AU2001276748A1 AU2001276748A AU7674801A AU2001276748A1 AU 2001276748 A1 AU2001276748 A1 AU 2001276748A1 AU 2001276748 A AU2001276748 A AU 2001276748A AU 7674801 A AU7674801 A AU 7674801A AU 2001276748 A1 AU2001276748 A1 AU 2001276748A1
Authority
AU
Australia
Prior art keywords
solid preparation
highly absorbable
absorbable solid
highly
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276748A
Inventor
Koichi Ishido
Katsuo Kataoka
Hiroshi Kikuchi
Hideo Kobayashi
Akira Kurosawa
Takahiro Shimaya
Tatsuya Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU2001276748A1 publication Critical patent/AU2001276748A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001276748A 2000-08-08 2001-08-07 Highly absorbable solid preparation Abandoned AU2001276748A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000239233 2000-08-08
JP2000-239233 2000-08-08
PCT/JP2001/006776 WO2002011726A1 (en) 2000-08-08 2001-08-07 Highly absorbable solid preparation

Publications (1)

Publication Number Publication Date
AU2001276748A1 true AU2001276748A1 (en) 2002-02-18

Family

ID=18730805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276748A Abandoned AU2001276748A1 (en) 2000-08-08 2001-08-07 Highly absorbable solid preparation

Country Status (14)

Country Link
US (2) US6861071B2 (en)
EP (1) EP1308160A4 (en)
JP (1) JP3573287B2 (en)
KR (1) KR100878667B1 (en)
CN (1) CN1214792C (en)
AR (1) AR030128A1 (en)
AU (1) AU2001276748A1 (en)
BR (1) BR0113055A (en)
CA (1) CA2417764C (en)
MX (1) MXPA03001206A (en)
NO (1) NO323835B1 (en)
RU (1) RU2287328C2 (en)
TW (1) TWI278316B (en)
WO (1) WO2002011726A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2610343A1 (en) * 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited Release-control composition
CN113777180B (en) * 2020-08-12 2023-05-02 济川药业集团有限公司 Method for simultaneously detecting sitafloxacin and various isomer impurities thereof
CN113181125B (en) * 2021-04-27 2022-07-19 海南通用三洋药业有限公司 Sitafloxacin hydrate tablet and preparation method thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
NZ245514A (en) * 1991-12-27 1994-12-22 Merck & Co Inc Controlled release drug delivery device comprising a core and a polymeric coating which is water impermeable but contains apertures to expose the core
ATE192932T1 (en) * 1993-09-09 2000-06-15 Takeda Chemical Industries Ltd FORMULATION CONTAINING AN ANTIBACTERIAL AND AN ANTIULCUS ACTIVE
DE69509442T2 (en) * 1994-06-16 1999-09-02 Lg Chemical Ltd. Quinoline carboxylic acid derivatives with 7- (4-amino-methyl-3-oxime) pyrrolidine substituents and process for their preparation
EP0775702B1 (en) * 1994-08-12 2003-07-23 Toyama Chemical Co., Ltd. Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
US6057323A (en) * 1996-03-08 2000-05-02 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) * 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
JP2000516222A (en) * 1996-08-15 2000-12-05 ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング Oral pharmaceutical composition that is easy to swallow
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
AU8038998A (en) * 1997-06-23 1999-01-04 Yoshitomi Pharmaceutical Industries, Ltd. Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
AUPO758297A0 (en) * 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
JP4299384B2 (en) 1997-07-15 2009-07-22 富山化学工業株式会社 Anti-elution delay fine granules
JP4299385B2 (en) 1997-07-15 2009-07-22 富山化学工業株式会社 Pazufloxacin fine granules
IN186245B (en) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DK1107741T3 (en) 1998-09-14 2003-11-17 Ranbaxy Lab Ltd Orally administered regulated management system providing temporal and spatial regulation

Also Published As

Publication number Publication date
US20030176452A1 (en) 2003-09-18
RU2287328C2 (en) 2006-11-20
MXPA03001206A (en) 2003-06-30
BR0113055A (en) 2003-07-08
EP1308160A1 (en) 2003-05-07
NO20030626L (en) 2003-02-07
KR20030040348A (en) 2003-05-22
AR030128A1 (en) 2003-08-13
US20040132756A1 (en) 2004-07-08
EP1308160A4 (en) 2005-01-19
JP3573287B2 (en) 2004-10-06
NO20030626D0 (en) 2003-02-07
NO323835B1 (en) 2007-07-09
CN1214792C (en) 2005-08-17
WO2002011726A1 (en) 2002-02-14
US6861071B2 (en) 2005-03-01
CA2417764A1 (en) 2002-02-14
KR100878667B1 (en) 2009-01-13
CN1444480A (en) 2003-09-24
CA2417764C (en) 2009-05-05
TWI278316B (en) 2007-04-11

Similar Documents

Publication Publication Date Title
AU2001281758A1 (en) Biocompatible materials
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001296577A1 (en) Chlorophyllases
AU2001259702A1 (en) Tissue regrafting
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001290931A1 (en) Ski-snowboard
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001241098A1 (en) Composition
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2001254731A1 (en) Substituted phenyluracils
AU2001281921A1 (en) Bdellosomes
AU2001275201A1 (en) Acne-treating composition
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones
AU2001287852A1 (en) Composition